Rheumatoid Arthritis
2,501 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis (NCT00650026) | Abbott |
Track Rheumatoid Arthritis automatically
Every clearance here is in the API, with alerts when new ones post.